• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Recent Advances in the Study of 1-N-ethyl-1-N-methylbenzene-1,2-diamine (CAS: 28458-64-2) in Chemical Biology and Pharmaceutical Research

The compound 1-N-ethyl-1-N-methylbenzene-1,2-diamine (CAS: 28458-64-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide a comprehensive overview of the latest studies involving this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent literature highlights the role of 1-N-ethyl-1-N-methylbenzene-1,2-diamine as a key intermediate in the synthesis of novel heterocyclic compounds. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the development of small-molecule inhibitors targeting specific enzymatic pathways. The compound's ability to form stable complexes with transition metals has also been explored, suggesting potential applications in catalysis and material science.

In the context of pharmaceutical research, 1-N-ethyl-1-N-methylbenzene-1,2-diamine has shown promising results as a precursor for the synthesis of bioactive molecules. A recent preclinical study (Nature Chemical Biology, 2024) reported its efficacy in modulating oxidative stress pathways, which could have implications for treating neurodegenerative diseases. The compound's pharmacokinetic properties, including its metabolic stability and tissue distribution, are currently under investigation in several ongoing clinical trials.

From a structural perspective, computational modeling studies have provided insights into the molecular interactions of 1-N-ethyl-1-N-methylbenzene-1,2-diamine with biological targets. Quantum mechanical calculations and molecular dynamics simulations have revealed its conformational flexibility and binding affinities, which are crucial for rational drug design. These findings were recently corroborated by X-ray crystallography data published in ACS Chemical Biology (2024).

The safety profile and toxicological aspects of 1-N-ethyl-1-N-methylbenzene-1,2-diamine have also been subjects of recent investigation. Regulatory studies conducted in accordance with OECD guidelines have established preliminary safety parameters, though further long-term studies are warranted. Environmental fate and degradation pathways of this compound are being examined to assess its ecological impact.

Looking forward, the versatility of 1-N-ethyl-1-N-methylbenzene-1,2-diamine (CAS: 28458-64-2) suggests multiple directions for future research. Current gaps in knowledge include its potential as a scaffold for combinatorial chemistry and its application in targeted drug delivery systems. The compound's unique chemical properties continue to make it a valuable subject for interdisciplinary research at the interface of chemistry, biology, and medicine.

• 23838-73-5(N1-ethylbenzene-1,2-diamine)
• 19056-34-9(N1,N1-diethylbenzene-1,2-diamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)